IGC PHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2013
Total Assets: $19.3M
Liabilities Breakdown FY2013
Total Liabilities: $4.3M
Asset Breakdown
Total Assets: $19.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.1M | 5.5% |
| Accounts Receivable | $1.1M | 5.5% |
| Inventory | $407.1K | 2.1% |
| Property, Plant & Equipment | $8.2M | 42.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $592.3K | 3.1% |
| Other Assets | $7.9M | 41.2% |
Liabilities Breakdown
Total Liabilities: $4.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $600.7K | 14.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $3.7M | 86.0% |